Dissertation > Excellent graduate degree dissertation topics show

The Clinical Contrast Research for Treating Acute Myocardial Infarction by Reteplase and Urokinase

Author: LiuBo
Tutor: WangWenZhi
School: Jilin University
Course: Internal Medicine
Keywords: myocardial infarction reteplase urokinase thrombolytic thrapy
CLC: R542.22
Type: Master's thesis
Year: 2005
Downloads: 67
Quote: 0
Read: Download Dissertation

Abstract


Coronary heart disease is one of the main diseases which are dangerous to the health of people . Acute myocardial infarction (AMI) is one of acute heart diseases , which is increasing year by year in our country . Myocardium is necrotic because of the lack of blood . On the base of the infarct-related coronary artery , the supply of the blood reduces or intermits sharply , which makes the corresponding myocardium necrotic because of the lack of blood continuously and severly . Clinical investigation has proved that over 80% of AMI which have lifted ST segment is because of the totally block of the coronary artery . The block is caused by thrombolysis . Thrombolytic thrapy has become one of the methods opening the blocked vessel at the early time of AMI . It can rescue the necrotic myocardium , reduce the area of infarction and complication and enhance survival rate . Reteplase (r-PA) , the third-generation thrombolytic drug , is a kind of recombinant tissue plasminogen activator . It is single-chain non-glycosyl-deletion variation of wild-type t-PA , which only contains the K2 area and P area of t-PA . Reteplase (r-PA) reserves the characteristic of t-PA because of the existence of K2 area . The lack of E area makes it have no affinity to fibre protein , so the half period of decadence prolongs (18min) , which is 6 time longer than wild-type t-PA .It also makes the action of thrombolysis 5.3 time stronger than t-PA and serous eliminated rate , 4.3 time lower than t-PA . Animal experiment indicated that r-PA can reach reperfusion faster than t-PA 、SK 、UK and reduce hemorrhage . In comparison with the thrombolytic drugs on the market , r-PA come into effect soon and it can be offered every 30min by injecting directly . It needn’t adjust the dosage following weight . So r-PA is more effective at present . Objective:Appraising the clinic effect and the adverse reaction in treating AMI between r-PA and UK . Method:77 patients with AMI during March 2003 to March 2005 were randomized to divide into r-PA group (35 cases) and UK group (42 cases) . The rate of thrombolytic and re-open dead rate during acute phase and adverse effects were observed . Result:The age, sex, infarction region and the time of treatment were not statistically different . For the r-PA group , the rate of re-open are separately 34.29% (30min) , 62.86% (60min) ,85.71% (120min) . For the UK group , the rate of re-open are separately 14.29% (30min) , 30.95% (60min) , 57.75% (120min) . The rate of re-open is higher in r-PA group than in UK group during every time period . The two groups were significantly statistically different . The rate of re-open during 30min and 60min in r-PA group are both higher that during 60min and 120min in UK group . The rate of re-open in r-PA group is ahead of that in UK

Related Dissertations

  1. The Value of the Heart-Type Fatty Acid Binding Protein in Early Diagnosis of Acute Myocardial Infarction,R542.22
  2. The Relationship of Polymorphisms of Methionine Synthase Reductase(MTRR) Gene and Plasma Homocysteine Levels with Myocardial Infarction,R542.22
  3. The Effects of Reserving Time of Filling Urokinase on Stereotactic Hematoma Aspiration of the Rabbit Intracerebral Hemotoma and the Heme Oxygenase -1 (HO-1) Expression,R743.3
  4. Relatinship of the Small, Dense Low-density Lipoprotein with Coronary Heart Disease and the Stenosis of Coronary Arteries,R541.4
  5. Impact of Different Infarct Coronary Artery on Prognosis of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction,R542.22
  6. The Relative Study of Gas 6 in Patients with Cardiac-cerebral Thrombosis Disease,R743
  7. Effect of Atorvastatin on the Concentration of Plasma Asymmetric Dimethylarginine in Acute Myocardial Infarction Patients during PCI Perioperative Period,R541.4
  8. Effect of PCI on Left Ventricular Regional Systolic Function in Patients with Acute Myocardial Infarction by STI,R542.22
  9. Research about the Clinical Effectiveness of ST-segment Elevation Acute Myocardial Infarction (STEMI) with Later Revascularization,R542.22
  10. The Short-term Prognosis of Different Treatment Methods and A Survey of Current Practice in Patients with Acute Myocardial Infarction of Ningxia Hui Autonomous Region.,R542.22
  11. Changing and Significance of Plasmic TNF-α and HsCRP in Patients with Acute Myocardial Infarction,R542.22
  12. The Expression and Significance of Fgl2 Prothrombinase and Cytokine TNF-α in the Peripheral Blood of Ami Patients and Heart Ischemia Reperfusion Rats Models.,R542.22
  13. Experimental Study of Transplantation into Rat Heart with Y Chromosome Labeled Bone Marrow-derived Mesenchymal Stem Cells,R654.2
  14. Expression of Upa and Microvessel Density Correlate with Invasion and Metasasis of Hypoharyngeal Squamous Cell Carcinmoma,R739.65
  15. In Vivo Molecular Imaging of Rosuvastatin on Adipose-derived Mesenchymal Stem Cells’ Survival and Mechanisms in Post-Infarcted Mice Hearts,R542.22
  16. Effects of Earlier Statin Therapy on Inflammatory Factors in Patients with Acute Myocardial Infarction,R542.22
  17. Mesenchymal stem cell transplantation in rats after acute myocardial infarction myocardial apoptosis,R542.22
  18. Clinical Study of rhBNP in Patients with Acute Myocardial Infarction Complicated with Acute Left Heart Failure,R542.22
  19. The Complement Activation and Drug Intervention in Rats with Acute Myocardial Infarction,R542.22
  20. The Corelation between Plasminogen Activator Inhibitor-1 and Recent Left Ventricular Remodeling and Prognosis after Acute Myocardial Infarction,R542.22
  21. Experimental Study of the Effects of Bone Marrow Mesenchymal Stem Cells Transfected with Sonic Hedgehog Gene for the Acute Ischemic Heart Disease,R542.22

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Heart disease > Myocardial diseases > Myocardial infarction
© 2012 www.DissertationTopic.Net  Mobile